The impact of UV360 on the locomotor activity of zebrafish larvae. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the neurophysiological activity of zebrafish larvae. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the viability and developmental progression of zebrafish embryos. by Lihan Xu (18778257)

Subjects:

The impact of UV360 on the development of spinal motor neuron axons in zebrafish larvae. by Lihan Xu (18778257)

Subjects:

<i>Kif15</i> deficiency leads to impaired development of dendritic spines in PFC and hippocampus of mice. by Xiaomei He (795333)

Subjects:

The primer sequences of real-time PCR. by Lihan Xu (18778257)

Subjects:

The outcomes of transcriptome analyses. by Lihan Xu (18778257)

Subjects:

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Forest plot of the association between vision impairment and difficulties with activity of daily living based on severity of vision impairment. by Masoud Rahmati (16665456)

Subjects:

Forest plot of the association between vision impairment and difficulties with activity of daily living based on different vision impairment characteristics. by Masoud Rahmati (16665456)

Subjects:

Sensitivity analysis for the association between vision impairment and difficulties with instrumental activity of daily living based on different vision impairment characteristics. by Masoud Rahmati (16665456)

Subjects:

Forest plot of the association between vision impairment and difficulties with instrumental activity of daily living based on different vision impairment characteristics. by Masoud Rahmati (16665456)

Subjects:

Everolimus decreased IgA1 deposits in glomeruli of α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Everolimus decreased mesangial TfR1 expression in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Study timeline and methodological overview. by Robert Botelho (20308297)

Subjects:

Longitudinal assessment of animal weights and tumor metrics. by Robert Botelho (20308297)

Subjects:

Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”